Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Lacerda, A.E.
Right arrow Articles by Brown, A.M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lacerda, A.E.
Right arrow Articles by Brown, A.M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Comparison of block among cloned cardiac potassium channels by non-antiarrhythmic drugs

A.E. Lacerdaa,1,2, J. Kramer1, K.-Z. Shen2, D. Thomas3 and A.M. Brown1,2

1 ChanTest, Inc., 14656 Neo Parkway, Cleveland, OH 44128, USA
2 Rammelkamp Center for Education and Research, MetroHealth Campus, Case Western Reserve University, Cleveland, OH 44109, U.S.A.
3 Department Of Cardiology, Medical University Hospital Heidelberg, Bergheimerstrasse 58, D-69115 Heidelberg, Germany

a Correspondence: Antonio E. Lacerda, ChanTest, Inc., 14656 Neo Parkway, Cleveland, OH 44128, U.S.A.

Abstract

Aims A major problem in contemporary therapeutics is to predict those non-antiarrhythmic drugs (nards) which might prolong the QT interval. Block of repolarizing cardiac K+ current is the most likely cause of drug-induced QT prolongation. In this paper we compared six members from four important classes of nards, antihistamines, anti-psychotics, antibiotics and prokinetics, for their block of the major repolarizing cardiac potassium currents IKr, IKs, ITo and IKur. The currents were produced by heterologous expression of HERG (KCNH2), MinK/KvLQT1 (KCNE1/ KCNQ1), Kv4·3 (KCND3) and Kv1·5 (KCNA5) respectively. To evaluate the effects of different cellular backgrounds HERG was expressed stably in HEK 293 and mouse L cells, and transiently in Xenopus laevis oocytes.

Methods and Results We measured currents with whole cell patch clamp and calculated IC50 values from dose-response curves at room and body temperatures. In all six cases HERG was the most sensitive target among the cloned K+ channels. HERG channels expressed in different mammalian cell lines had similar IC50 values. IC50 values were five to one hundred times larger when HERG was expressed transiently in Xenopus oocytes. Block was temperature-dependent but the effects were small and variable. For the nards terfenadine, sertindole and cisapride that have been withdrawn from the drug market, the IC50 values for HERG block were nanomolar, within the range for block of the primary target, and therefore within the therapeutic range.

Conclusion Cloned ion channel assays are robust pre-clinical predictors of non-cardiac proarrhythmic drugs.

Key Words: Non-antiarrhythmic drugs • acquired long QT syndrome • drug induced QT prolongation • cardiac potassium channels • HERG

References

  1. Warmke JW, Ganetzky BA. A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci USA. 1994. p. 3438–3442
  2. Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell. 1995;81:299–307[CrossRef][Web of Science][Medline]
  3. Wang Q, Curran ME, Splawski I, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet. 1996;12:17–23[CrossRef][Web of Science][Medline]
  4. Murai T, Kakizuka A, Takumi T, Ohkubo H, Nakanishi S. Molecular cloning and sequence analysis of human genomic DNA encoding a novel membrane protein which exhibits a slowly activating potassium channel activity. Biochem Biophys Res Commun. 1989;161:176–181[CrossRef][Web of Science][Medline]
  5. Sanguinetti MC, Curran ME, Zou A, et al. Coassembly of K~LQTI and minK (IsK) proteins to form cardiac IK, potassium channel. Nature (London). 1996;384:80–83[CrossRef][Medline]
  6. Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet. 1997;17:338–340[Web of Science][Medline]
  7. Abbott GW, Sesti F, Splawski I, et al. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell. 1999;97:175–187[CrossRef][Web of Science][Medline]
  8. Bennett PB, Yazawa K, Makita N, George AL Jr.. Molecular mechanism for an inherited cardiac arrhythmia. Nature. 1995;376:683–685[CrossRef][Medline]
  9. Wang Q, Shen J, Splawski I, et al. SCN5A Mutations Associated with an Inherited Cardiac Arrhythmia, Long QT Syndrome. Cell. 1995;80:805–811[CrossRef][Web of Science][Medline]
  10. Roy M, Dumaine R, Brown AM. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine [see comments]. Circulation. 1996;94:817–823[Abstract/Free Full Text]
  11. Pratt CM, Mason J, Russell T, Reynolds R, Ahlbrandt R. Cardiovascular safety of fexofenadine HCI. Am J Cardiol. 1999;83:1451–1454[CrossRef][Web of Science][Medline]
  12. Kang J, Wang L, Cai F, Rampe D. High affinity blockade of the HERG cardiac K(+) channel by the neuroleptic pimozide. Eur J Pharmacol. 2000;392:137–140[CrossRef][Web of Science][Medline]
  13. Rampe D, Murawsky MK, Gran J, Lewis EW. The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG. J Pharmacol Exp Ther. 1998;286:788–793[Abstract/Free Full Text]
  14. Rampe D, Roy ML, Dennis A, Brown AM. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG. FEBS Lett. 1997;417:28–32[CrossRef][Web of Science][Medline]
  15. Mohammad S, Zhou Z, Gong Q, January CT. Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride. Am J Physiol. 1997;273:H2534–H2538
  16. Fedida D, Wible B, Wang Z, et al. Identity of a novel delayed rectifier current from human heart with a cloned K+ channel current. Circ Res. 1993;73:210–216[Abstract]
  17. Tamkun MM, Knoth KM, Walbridge JA, Kroemer H, Roden DM, Glover DM. Molecular cloning and characterization of two voltage-gated K+ channel cDNAs from human ventricle. FASEB J. 1991;5:331–337[Abstract]
  18. Wang Z, Fermini B, Nattel S. Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovasc Res. 1994;28:1540–1546[Web of Science][Medline]
  19. Wang Z, Fermini B, Nattel S. Effects of Flecainide, Quinidine, and 4-Aminopyridine on Transient Outward and Ultrarapid Delayed Rectifier Currents in Human Atrial Myocytes. J Pharmacol Exper Ther. 1995;272:184–196[Abstract/Free Full Text]
  20. Rampe D, Wang Z, Fermini B, Wible B, Dage RC, Nattel S. Voltage-and Time-Dependent Block by Perhexiline of K+ Currents in Human Atrium and in Cells Expressing a Kv1–5 Type Cloned Channel. J Pharmacol Exper Ther. 1995;274:444–449[Abstract/Free Full Text]
  21. Rampe D, Wible B, Brown AM, Dage RC. Effects of Terfenadine and Its metabolites on a Delayed Rectifier K+ Channel Cloned from Human Heart. Mol Pharmacol. 1993;44:1240–1245[Abstract]
  22. Lacerda AE, Roy ML, Lewis EW, Rampe D. Interactions of the nonsedating antihistamine loratadine with a Kv1–5 type potassium channel cloned from human heart. published erratum appears inMol Pharmacol. 1997;52:754Lacerda AE, Roy ML, Lewis EW, Rampe D. Mol Pharmacol. 1997;52:314–322[Abstract/Free Full Text]
  23. Bosch RE, Gaspo R, Busch AE, Lang HL, Li GR, Nattel S. Effects of the chromanol 293B, a selective blocker of the slow, component of the delayed rectifier K+ current, on repolarization in human and guinea pig ventricular myocytes. Cardiovasc Res. 1998;38:441–450[Abstract/Free Full Text]
  24. Turgeon J, Deleau P, Bennett P, Wiggins S, Selby L, Roden D. Block of IKs, the Slow Component of the Delayed Rectifier K+ Current, by the Diuretic Agent Indapamide in Guinea Pig Myocytes. Circ Res. 1994;75:879–886[Abstract/Free Full Text]
  25. Davies MP, Freeman LC, Kass RS. Dual actions of the novel class III antiarrhythmic drug NE-10 064 on delayed potassium channel currents in guinea pig ventricular and sinoatrial node cells. J Pharmacol Exper Ther. 1996;276:1149–1154[Abstract/Free Full Text]
  26. Crumb WJ Jr.. Rate-dependent blockade of a potassium current in human atrium by the antihistamine loratadine. Br J Pharmacol. 1999;126:575–580[CrossRef][Web of Science][Medline]
  27. Furutani M, Trudeau MC, Hagiwara N, et al. Novel mechanism associated with an inherited cardiac arrhythmia: defective protein trafficking by the mutant HERG (G601S) potassium channel. Circulation. 1999;99:2290–2294[Abstract/Free Full Text]
  28. Brown AM, Rampe D. Drug-induced long QT syndrome: is HERG the root of all evil. Pharmaceutical News. 2000;7:15–20
  29. Salata JJ, Jurkiewicz NK, Wallace AA, Stupienski RE, Guinosso PL, Lynch JJ. Cardiac electrophysiological actions of the histamine H1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine. Circ Res. 1995;76:110–119[Abstract/Free Full Text]
  30. Ki I, Inui A, Ito T. Effects of histamine H1 receptor antagonists on action potentials in guinea-pig isolated papillary muscles. Arch Int Pharmacodyn Ther. 1996;331:59–73[Web of Science][Medline]
  31. Rampe D. Voltage-dependent potassium channels cloned from human heart: New tools to predict the pro-arrhythmic potential of drugs. Ion Channel Modulators. 1997;2:331–733
  32. Rampe D, Murawsky MK. Blockade of the human cardiac K+ channel Kv1·5 by the antibiotic erythromycin. Naunyn Schmiedebergs Arch Pharmacol. 1997;355:743–750[CrossRef][Web of Science][Medline]
  33. McDonald TV, Yu Z, Ming Z, et al. A mink-HERG complex regulates the cardiac potassium current IKr,. Nature (London). 1997;388:289–292[CrossRef][Web of Science][Medline]
  34. Ficker E, Jarolimek W, Kiehn J, Baumann A, Brown AM. Molecular determinants of dofetilide block of HERG K+ channels. Circ Res. 1998;82:386–395[Abstract/Free Full Text]
  35. Kiehn J, Lacerda AE, Wible B, Brown AM. Molecular physiology and pharmacology of HERG: single channel currents and block by dofetilide. Circulation. 1996;94:2572–2579[Abstract/Free Full Text]
  36. Zhou Z, Vorperian VR, Gong Q, Zhang S, January CT. Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole. J Cardiovasc Electrophysiol. 1999;10:836–843[Web of Science][Medline]
  37. Taglialatela M, Pannaccione A, Castaldo P, et al. Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines. Mol Pharmacol. 1998;54:113–121[Abstract/Free Full Text]
  38. Yang T, Prakash C, Roden DM, Snyders DJ. Mechanism of block of a human cardiac potassium channel by terfenadine racemate and enantiomers. Br J Pharmacol. 1995;115:267–274[Web of Science][Medline]
  39. Lees-Miller JP, Duan Y, Teng GQ, Duff HJ. Molecular determinant of high-affinity dofetilide binding to HERGI expressed in Xenopus oocytes: involvement of S6 sites. Mol Pharmacol. 2000;57:367–374[Abstract/Free Full Text]
  40. Schotte A, Janssen PF, Gommeren W, et al. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl). 1996;124:57–73[CrossRef][Medline]
  41. Mine Y, Yoshikawa T, Oku S, Nagai R, Yoshida N, Hosoki K. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro. J Pharmacol Exp Ther. 1997;283:1000–1008[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
A. E. Lacerda, Y. A. Kuryshev, Y. Chen, M. Renganathan, H. Eng, S. J. Danthi, J. W. Kramer, T. Yang, and A. M. Brown
Alfuzosin Delays Cardiac Repolarization by a Novel Mechanism
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 427 - 433.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Lacerda, A.E.
Right arrow Articles by Brown, A.M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lacerda, A.E.
Right arrow Articles by Brown, A.M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?